UMPS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.066600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.393570E-01
Normal-vs-Stage2
3.777200E-01
Normal-vs-Stage3
8.281000E-01
Normal-vs-Stage4
1.640010E-01
Stage1-vs-Stage2
4.607600E-01
Stage1-vs-Stage3
1.163580E-01
Stage1-vs-Stage4
3.023400E-01
Stage2-vs-Stage3
1.837980E-01
Stage2-vs-Stage4
3.388200E-02
Stage3-vs-Stage4
1.128150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.244400E-01
Normal-vs-AfricanAmerican
4.559600E-01
Normal-vs-Asian
3.581800E-01
Caucasian-vs-AfricanAmerican
9.350800E-01
Caucasian-vs-Asian
8.913400E-01
AfricanAmerican-vs-Asian
8.612200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.580000E-01
Normal-vs-Female
3.501600E-01
Male-vs-Female
6.289600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.475400E-01
Normal-vs-Age(41-60Yrs)
3.531600E-01
Normal-vs-Age(61-80Yrs)
4.935800E-01
Normal-vs-Age(81-100Yrs)
1.093580E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.516000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.055800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.889400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.341800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.873600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.125440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.699800E-01
Normal-vs-Daily Drinker
6.362000E-01
Normal-vs-Weekly Drinker
4.464200E-01
Normal-vs-Occasional Drinker
1.822370E-01
Normal-vs-Social Drinker
3.403600E-01
Non Drinker-vs-Daily Drinker
9.660000E-01
Non Drinker-vs-Weekly Drinker
5.160800E-01
Non Drinker-vs-Occasional Drinker
2.695900E-02
Non Drinker-vs-Social Drinker
4.406400E-01
Daily Drinker-vs-Weekly Drinker
5.511800E-01
Daily Drinker-vs-Occasional Drinker
5.030200E-02
Daily Drinker-vs-Social Drinker
4.805400E-01
Weekly Drinker-vs-Occasional Drinker
2.330000E-01
Weekly Drinker-vs-Social Drinker
9.645800E-01
Occasional Drinker-vs-Social Drinker
2.064200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.925000E-01
Normal-vs-Grade 2
7.001600E-02
Normal-vs-Grade 3
5.091600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.315500E-03
Grade 1-vs-Grade 3
1.002490E-04
Grade 1-vs-Grade 4
3.925000E-01
Grade 2-vs-Grade 3
2.752300E-02
Grade 2-vs-Grade 4
7.001600E-02
Grade 3-vs-Grade 4
5.091600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.860000E-01
Normal-vs-NonDiabetic
3.904400E-01
Diabetic-vs-NonDiabetic
7.558600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.784770E-01
Normal-vs-NoPancreatitis
4.572200E-01
Pancreatitis-vs-NoPancreatitis
3.599200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.933400E-01
Normal-vs-N1
3.870000E-01
N0-vs-N1
8.255200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.061900E-02
Normal-vs-TP53-NonMutant
5.095600E-01
TP53-Mutant-vs-TP53-NonMutant
5.194300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
